Hinge Health (NYSE:HNGE) Now Covered by Needham & Company LLC

Needham & Company LLC began coverage on shares of Hinge Health (NYSE:HNGE) in a report published on Monday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $47.00 target price on the stock.

Other equities analysts also recently issued reports about the company. KeyCorp assumed coverage on Hinge Health in a research report on Monday. They set an “overweight” rating and a $45.00 price objective for the company. Barclays assumed coverage on Hinge Health in a research report on Monday. They set an “overweight” rating and a $43.00 price objective for the company. Wall Street Zen upgraded Hinge Health to a “hold” rating in a research report on Monday, June 2nd. Finally, Canaccord Genuity Group assumed coverage on Hinge Health in a research report on Monday. They set a “buy” rating and a $52.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, Hinge Health has an average rating of “Moderate Buy” and a consensus price target of $46.00.

Hinge Health Stock Up 5.2%

Shares of HNGE stock opened at $36.65 on Monday. Hinge Health has a 12 month low of $33.42 and a 12 month high of $43.80.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.